Literature DB >> 18840361

Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance.

Libin Liu1, Dennis Brown, Mary McKee, Nathan K Lebrasseur, Dan Yang, Kenneth H Albrecht, Katya Ravid, Paul F Pilch.   

Abstract

Caveolae are specialized invaginations of the plasma membrane found in numerous cell types. They have been implicated as playing a role in a variety of physiological processes and are typically characterized by their association with the caveolin family of proteins. We show here by means of targeted gene disruption in mice that a distinct caveolae-associated protein, Cavin/PTRF, is an essential component of caveolae. Animals lacking Cavin have no morphologically detectable caveolae in any cell type examined and have markedly diminished protein expression of all three caveolin isoforms while retaining normal or above normal caveolin mRNA expression. Cavin-knockout mice are viable and of normal weight but have higher circulating triglyceride levels, significantly reduced adipose tissue mass, glucose intolerance, and hyperinsulinemia--characteristics that constitute a lipodystrophic phenotype. Our results underscore the multiorgan role of caveolae in metabolic regulation and the obligate presence of Cavin for caveolae formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840361      PMCID: PMC2581738          DOI: 10.1016/j.cmet.2008.07.008

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  44 in total

1.  Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver.

Authors:  E D Abel; O Peroni; J K Kim; Y B Kim; O Boss; E Hadro; T Minnemann; G I Shulman; B B Kahn
Journal:  Nature       Date:  2001-02-08       Impact factor: 49.962

Review 2.  Multiple functions of caveolin-1.

Authors:  Pingsheng Liu; Michael Rudick; Richard G W Anderson
Journal:  J Biol Chem       Date:  2002-08-19       Impact factor: 5.157

3.  Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.

Authors:  R C Betz; B G Schoser; D Kasper; K Ricker; A Ramírez; V Stein; T Torbergsen; Y A Lee; M M Nöthen; T F Wienker; J P Malin; P Propping; A Reis; W Mortier; T J Jentsch; M Vorgerd; C Kubisch
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

4.  A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation.

Authors:  M Vorgerd; K Ricker; F Ziemssen; W Kress; H H Goebel; W A Nix; C Kubisch; B G Schoser; W Mortier
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

5.  Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.

Authors:  Babak Razani; Terry P Combs; Xiao Bo Wang; Philippe G Frank; David S Park; Robert G Russell; Maomi Li; Baiyu Tang; Linda A Jelicks; Philipp E Scherer; Michael P Lisanti
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

Review 6.  Triglycerides, fatty acids and insulin resistance--hyperinsulinemia.

Authors:  E W Kraegen; G J Cooney; J Ye; A L Thompson
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

7.  A 60-kDa protein abundant in adipocyte caveolae.

Authors:  J Vinten; M Voldstedlund; H Clausen; K Christiansen; J Carlsen; J Tranum-Jensen
Journal:  Cell Tissue Res       Date:  2001-07       Impact factor: 5.249

Review 8.  Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus.

Authors:  Kitt F Petersen; Gerald I Shulman
Journal:  Am J Cardiol       Date:  2002-09-05       Impact factor: 2.778

9.  Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.

Authors:  David S Park; Scott E Woodman; William Schubert; Alex W Cohen; Philippe G Frank; Madhulika Chandra; Jamshid Shirani; Babak Razani; Baiyu Tang; Linda A Jelicks; Stephen M Factor; Louis M Weiss; Herbert B Tanowitz; Michael P Lisanti
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

10.  Caveolin, cholesterol, and lipid droplets?

Authors:  G van Meer
Journal:  J Cell Biol       Date:  2001-03-05       Impact factor: 10.539

View more
  153 in total

1.  Probing the caveolin-1 P132L mutant: critical insights into its oligomeric behavior and structure.

Authors:  Monica D Rieth; Jinwoo Lee; Kerney Jebrell Glover
Journal:  Biochemistry       Date:  2012-04-25       Impact factor: 3.162

Review 2.  The dynamic roles of intracellular lipid droplets: from archaea to mammals.

Authors:  Denis J Murphy
Journal:  Protoplasma       Date:  2011-10-15       Impact factor: 3.356

3.  Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis.

Authors:  Weihua Fei; Hui Li; Guanghou Shui; Tamar S Kapterian; Christopher Bielby; Ximing Du; Andrew J Brown; Peng Li; Markus R Wenk; Pingsheng Liu; Hongyuan Yang
Journal:  J Lipid Res       Date:  2011-09-26       Impact factor: 5.922

Review 4.  Molecular mechanisms of clathrin-independent endocytosis.

Authors:  Carsten G Hansen; Benjamin J Nichols
Journal:  J Cell Sci       Date:  2009-06-01       Impact factor: 5.285

5.  Cavin fever: regulating caveolae.

Authors:  Ivan R Nabi
Journal:  Nat Cell Biol       Date:  2009-07       Impact factor: 28.824

6.  Caveolae and lipid trafficking in adipocytes.

Authors:  Paul F Pilch; Tova Meshulam; Shiying Ding; Libin Liu
Journal:  Clin Lipidol       Date:  2011

Review 7.  Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation.

Authors:  John H Chidlow; William C Sessa
Journal:  Cardiovasc Res       Date:  2010-03-03       Impact factor: 10.787

8.  Mitochondrial cholesterol: a connection between caveolin, metabolism, and disease.

Authors:  Marta Bosch; Montserrat Marí; Steven P Gross; José C Fernández-Checa; Albert Pol
Journal:  Traffic       Date:  2011-08-25       Impact factor: 6.215

9.  IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.

Authors:  Elena Scotti; Martino Calamai; Chris N Goulbourne; Li Zhang; Cynthia Hong; Ron R Lin; Jinkuk Choi; Paul F Pilch; Loren G Fong; Peng Zou; Alice Y Ting; Francesco S Pavone; Stephen G Young; Peter Tontonoz
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

10.  Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability.

Authors:  Sergio Perez-Diaz; Lance A Johnson; Robert M DeKroon; Jose M Moreno-Navarrete; Oscar Alzate; Jose M Fernandez-Real; Nobuyo Maeda; Jose M Arbones-Mainar
Journal:  FASEB J       Date:  2014-05-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.